LP
TVGN icon

LMR Partners’s Tevogen Bio Holdings TVGN Stock Holding History

LMR Partners’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,000
Closed -$4.13M – 1177
2022
Q4 		$4.13M Buy
+8,000
New +$4.09M 0.07% 309

Other funds holding TVGN

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LMR Partners's TVGN Position: Q1 2023 in Review

LMR Partners sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 8,000 shares — an estimated $4.13M sold.

LMR Partners first reported a position in TVGN in Q4 2022 and held it in 1 quarter. The position peaked at $4.13M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

  • LMR Partners reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
  • LMR Partners sold 8,000 Tevogen Bio Holdings shares in Q1 2023, an estimated $4.13M.
  • LMR Partners first reported a position in Tevogen Bio Holdings in Q4 2022 and held it in 1 quarter.
  • LMR Partners's Tevogen Bio Holdings position peaked at $4.13M in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on LMR Partners's 13F filing for Q1 2023, filed 15 May 2023.